Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology
Link
http://www.nature.com/articles/cdd201431.pdf
Reference45 articles.
1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987–996.
2. Hau P, Koch D, Hundsberger T, Marg E, Bauer B, Rudolph R et al. Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma. Neurology 2007; 68: 688–690.
3. Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012; 488: 522–526.
4. Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW et al. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 2009; 4: 226–235.
5. Beier D, Schulz JB, Beier CP . Chemoresistance of glioblastoma cancer stem cells—much more complex than expected. Mol cancer 2011; 10: 128.
Cited by 278 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Systematic Review of the Metabolism of High-Grade Gliomas: Current Targeted Therapies and Future Perspectives;International Journal of Molecular Sciences;2024-01-05
2. Glioma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioma resistance to temozolomide;2024-01-02
3. Quenching thirst with poison? Paradoxical effect of anticancer drugs;Pharmacological Research;2023-12
4. FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2‐Mediated Alternative Splicing;Advanced Science;2023-10-11
5. Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers;International Journal of Molecular Sciences;2023-09-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3